Showing results (321-330 of 1,794) with videos related to

Sort By:
Pageof 180
Mabs|August 7, 2012
Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritisPalanisamy Kanakaraj, Bridget A Puffer, Xiao-Tao Yao, et al.
Mabs|September 26, 2012
Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621Neil R Michaud, Jitesh P Jani, Stephen Hillerman, et al.
Mabs|June 16, 2012
Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycansMarcella Yu, Darren Brown, Chae Reed, et al.
Mabs|July 24, 2012
Peptibodies: A flexible alternative format to antibodiesGrant Shimamoto, Colin Gegg, Tom Boone, et al.
Mabs|July 24, 2012
Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodiesYi Du, Alison Walsh, Robin Ehrick, et al.
Mabs|July 24, 2012
CD19 as an attractive target for antibody-based therapyOhad Hammer
Mabs|July 24, 2012
The assay design used for measurement of therapeutic antibody concentrations can affect pharmacokinetic parameters: Case studiesSaloumeh K Fischer, Jihong Yang, Banmeet Anand, et al.
Mabs|March 23, 2010
Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1Mei-Yun Zhang, Andrew Rosa Borges, Roger G Ptak, et al.
Mabs|February 7, 2015
The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinityYasmina Noubia Abdiche, Yik Andy Yeung, Javier Chaparro-Riggers, et al.
Mabs|February 11, 2015
Macrophages are critical effectors of antibody therapies for cancerKipp Weiskopf, Irving L Weissman
Pageof 180